These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33017199)
21. Iontophoresis for the cutaneous delivery of nanoentraped drugs. Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173 [TBL] [Abstract][Full Text] [Related]
22. Analysing the skin barrier from down under. Grice J; Benson HA Skin Pharmacol Physiol; 2013; 26(4-6):254-62. PubMed ID: 23921112 [TBL] [Abstract][Full Text] [Related]
23. Spray-on transdermal drug delivery systems. Ibrahim SA Expert Opin Drug Deliv; 2015 Feb; 12(2):195-205. PubMed ID: 25227233 [TBL] [Abstract][Full Text] [Related]
24. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery. Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113 [TBL] [Abstract][Full Text] [Related]
25. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes. Anissimov YG; Jepps OG; Dancik Y; Roberts MS Adv Drug Deliv Rev; 2013 Feb; 65(2):169-90. PubMed ID: 22575500 [TBL] [Abstract][Full Text] [Related]
26. Microneedle system: a modulated approach for penetration enhancement. Khare N; Shende P Drug Dev Ind Pharm; 2021 Aug; 47(8):1183-1192. PubMed ID: 34634991 [TBL] [Abstract][Full Text] [Related]
27. A linear theory of transdermal transport phenomena. Edwards DA; Langer R J Pharm Sci; 1994 Sep; 83(9):1315-34. PubMed ID: 7830250 [TBL] [Abstract][Full Text] [Related]
28. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010 [TBL] [Abstract][Full Text] [Related]
29. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM; Corish J; Corrigan OI; Fitzpatrick D Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130 [TBL] [Abstract][Full Text] [Related]
30. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery. Wong TW J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250 [TBL] [Abstract][Full Text] [Related]
32. Nanomaterial and advanced technologies in transdermal drug delivery. Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847 [TBL] [Abstract][Full Text] [Related]
33. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure. Dancik Y; Miller MA; Jaworska J; Kasting GB Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584 [TBL] [Abstract][Full Text] [Related]
34. Potential of peptide-based enhancers for transdermal delivery. Lopes LB; Carvalho VF; de Lemos DP Curr Pharm Des; 2015; 21(20):2814-22. PubMed ID: 25925116 [TBL] [Abstract][Full Text] [Related]
35. Microneedles for transdermal drug delivery: a minireview. Vandervoort J; Ludwig A Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662 [TBL] [Abstract][Full Text] [Related]
36. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis. Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397 [TBL] [Abstract][Full Text] [Related]
37. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review. Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470 [No Abstract] [Full Text] [Related]
38. An overview on the advantages and limitations of 3D printing of microneedles. Ozyilmaz ED; Turan A; Comoglu T Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288 [TBL] [Abstract][Full Text] [Related]
39. Modeling transdermal drug release. Kalia YN; Guy RH Adv Drug Deliv Rev; 2001 Jun; 48(2-3):159-72. PubMed ID: 11369080 [TBL] [Abstract][Full Text] [Related]
40. Microneedles and transdermal applications. Sivamani RK; Liepmann D; Maibach HI Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]